Recombinant human granulocyte–colony‐stimulating factor–mobilized and apheresis‐collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis

Abstract

Circulating EPCs represent a novel blood cell component that can be collected by apheresis in large quantities and can be used clinically, either unmanipulated or EPC-selected, for therapeutic vasculogenesis.